1 Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20-23 March 2019: personalised treatments for patients with early breast cancer.

2 role of percutaneous needle biopsy of axillary lymph nodes to evaluate node positive breast cancer after neoadjuvant chemotherapy

3 Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial.

4 [Urinary tract hemangiopericytoma treated with radical surgery and neoadjuvant chemotherapy. Report of two cases.].

5 [Clinical Retrospective Analysis of Chronic Myeloid Leukemia in Myeloid Blast Crisis].

6 Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases

7 Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy

8 The Value of Intravoxel Incoherent Motion (IVIM) Magnetic Resonance Imaging in the Evaluation of the Osteosarcoma Response to Preoperative Neoadjuvant Chemotherapy in Teens

9 Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.

10 [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].

11 A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.

12 Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab.

13 Cancer of the oesophagus and lymph nodes management in the neoadjuvant or definitive radiochemotherapy setting.

14 Direct-to-implant breast reconstruction after neoadjuvant chemotherapy: A safe option?

15 Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.

16 Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer.

17 Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.

18 Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review.

19 Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence

20 Short-term outcomes of laparoscopically assisted surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single-center experience.

21 The NeST (neoadjuvant systemic therapy in breast cancer) study - Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer.

22 Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features

23 Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.

24 Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

25 Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.

26 Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab

27 Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy

28 effect of zhenwu decoction combined with neoadjuvant chemotherapy on malignant characteristics of cancer cells in ovarian cancer

29 tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment

30 adenocarcinoma mucinoso sobre fístula perianal de largo tiempo de evolución, tratado mediante qt-rt neoadyuvante y amputación abdómino-perienal laparoscópica mucinous adenocarcinoma on chronic perianal fistula treated by neoadjuvant qt-rt and laparoscopic abdomino-perineal resection

31 effects of laparoscopic operation combined neoadjuvant chemotherapy on serum levels of cea, ca242, ca19-9, ca724, icam-1 and vcam-1 in patients with colorectal carcinoma

32 efficacy of anti-her2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced her2-positive breast cancer patients: a network meta-analysis

33 pulmonary sarcoidosis activation following neoadjuvant pembrolizumab plus chemotherapy combination therapy in a patient with non-small cell lung cancer: a case report

34 breast dce-mri kinetic heterogeneity tumor markers: preliminary associations with neoadjuvant chemotherapy response

35 surgical resection with neoadjuvant chemotherapy for locoregionally recurrent appendiceal cancer invading the external iliac vessels

36 quimioterapia neoadjuvante seguida de cirurgia radical em paciente grávida com câncer de colo de útero: relato de caso e revisão de literatura neoadjuvant chemotherapy followed by radical surgery in pregnant patient with invasive cervical cancer: case report and literature review

37 neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of enneking stage ii: a retrospective study

38 neoadjuvant therapy in pancreatic cancer: an emerging strategy

39 the value of combined large format histopathology technique to assess the surgically removed breast tissue following neoadjuvant chemotherapy: a single institution study of 40 cases

40 prospective analysis of 18f-fdg pet/ct predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery

41 clinical efficacy of breast-conserving surgery combined with neoadjuvant chemotherapy for locally advanced breast cancer: a report of 81 cases

42 neoadjuvant therapy in differentiated thyroid cancer

43 effect of neoadjuvant chemotherapy on low-density lipoprotein (ldl) receptor and ldl receptor-related protein 1 (lrp-1) receptor in locally advanced breast cancer

44 predicting treatment response of breast cancer to neoadjuvant chemotherapy using ultrasound-guided diffuse optical tomography

45 linfadenectomia lateral pÉlvica laparoscÓpica durante excisÃo total do mesorreto no tratamento do cÂncer de reto localmente avanÇado pÓs‐quimiorradioterapia neoadjuvante

46 neoadjuvant chemotherapy in locally advanced and borderline resectable nonsquamous sinonasal tumors (esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation)

47 intensified neoadjuvant chemotherapy with nab-paclitaxel plus gemcitabine followed by folfirinox in a patient with locally advanced unresectable pancreatic cancer

48 locoregional recurrence risk in breast cancer patients with estrogen receptor positive tumors and residual nodal disease following neoadjuvant chemotherapy and mastectomy without radiation therapy

49 time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: a population study on 2094 patients

50 topoisomerase ii alpha and tle3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer

51 neoadjuvant chemotherapy and salvage surgery for an aldosterone-producing adrenal carcinoma with inferior vena cava thrombus: case report and literature review

52 Neoadjuvant chemoradiation for adenocarcinoma of the pancreas

53 Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery?

54 Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) A comparison between two multicenter randomized phase II/III trials.

55 Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

56 Axillary sparganosis which was misunderstood lymph node metastasis during neoadjuvant chemotheraphy in a breast cancer patient

57 Pathological responses and long-term outcome analysis after neoadjuvant chemotheraphy in breast cancer patients from Kuwait over a period of 15 years

58 Predictive value of ADC for the effect of neoadjuvant chemotheraphy on breast cancer: A prospective exploration

59 FACTORS AFFECTING DISEASE FREE AND OVERALL SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPHY (LABC) (THE 10-YEAR RESULTS)

60 Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer.

61 Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.

62 Real-Life Data of Neoadjuvant Chemotherapy in Breast Cancer: Aegean Region Experience

63 Meticulous initial clinical and pathological staging with standardized long-term follow-up after radical cystectomy is required to validate and improve overall prognostic performance in patients undergoing neoadjuvant chemotherapy for bladder cancer.

64 Node positive breast cancer: Concordance between baseline PET/CT and sentinel node assessment after neoadjuvant therapy.

65 Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings

66 Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder carcinoma: A narrative review.

67 Evaluation of Efficacy of Neoadjuvant Immunochemotherapy for Cervical Metastatic Squamous Cell Carcinoma of Unknown Primary.

68 Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell Carcinoma.

69 Preoperative Neoadjuvant Chemotherapy or Immunotherapy in Head and Neck Cancer: A Systematic Review and Meta-Analysis of Surgical Risk and Pathologic Response.

Keyword Connections

Journals

Research Groups

Bibliographies